PMC:7289100 / 11475-11738 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T175","span":{"begin":27,"end":35},"obj":"Disease"},{"id":"T176","span":{"begin":71,"end":81},"obj":"Disease"},{"id":"T177","span":{"begin":85,"end":91},"obj":"Disease"}],"attributes":[{"id":"A175","pred":"mondo_id","subj":"T175","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A176","pred":"mondo_id","subj":"T176","obj":"http://purl.obolibrary.org/obo/MONDO_0000831"},{"id":"A177","pred":"mondo_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/MONDO_0005098"},{"id":"A178","pred":"mondo_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/MONDO_0011057"}],"text":"Vascular manifestations of COVID-19 comprise either venous or arterial thrombosis or stroke in subjects under the age of 50, sometimes with a severe phenotype that can resemble the “catastrophic” clinical picture associated with antiphospholipid antibodies (aPL)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T106","span":{"begin":62,"end":70},"obj":"http://purl.obolibrary.org/obo/UBERON_0001637"},{"id":"T107","span":{"begin":62,"end":70},"obj":"http://www.ebi.ac.uk/efo/EFO_0000814"},{"id":"T108","span":{"begin":140,"end":141},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Vascular manifestations of COVID-19 comprise either venous or arterial thrombosis or stroke in subjects under the age of 50, sometimes with a severe phenotype that can resemble the “catastrophic” clinical picture associated with antiphospholipid antibodies (aPL)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T93","span":{"begin":62,"end":81},"obj":"Phenotype"},{"id":"T94","span":{"begin":85,"end":91},"obj":"Phenotype"},{"id":"T95","span":{"begin":229,"end":256},"obj":"Phenotype"},{"id":"T96","span":{"begin":258,"end":261},"obj":"Phenotype"}],"attributes":[{"id":"A93","pred":"hp_id","subj":"T93","obj":"http://purl.obolibrary.org/obo/HP_0004420"},{"id":"A94","pred":"hp_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/HP_0001297"},{"id":"A95","pred":"hp_id","subj":"T95","obj":"http://purl.obolibrary.org/obo/HP_0003613"},{"id":"A96","pred":"hp_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/HP_0003613"}],"text":"Vascular manifestations of COVID-19 comprise either venous or arterial thrombosis or stroke in subjects under the age of 50, sometimes with a severe phenotype that can resemble the “catastrophic” clinical picture associated with antiphospholipid antibodies (aPL)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T78","span":{"begin":0,"end":263},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Vascular manifestations of COVID-19 comprise either venous or arterial thrombosis or stroke in subjects under the age of 50, sometimes with a severe phenotype that can resemble the “catastrophic” clinical picture associated with antiphospholipid antibodies (aPL)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T198","span":{"begin":27,"end":35},"obj":"SP_7"},{"id":"T199","span":{"begin":52,"end":58},"obj":"UBERON:0001638"},{"id":"T200","span":{"begin":62,"end":70},"obj":"UBERON:0001637"},{"id":"T201","span":{"begin":71,"end":81},"obj":"GO:0007596"},{"id":"T202","span":{"begin":246,"end":256},"obj":"GO:0042571"},{"id":"T41700","span":{"begin":27,"end":35},"obj":"SP_7"},{"id":"T38805","span":{"begin":52,"end":58},"obj":"UBERON:0001638"},{"id":"T16502","span":{"begin":62,"end":70},"obj":"UBERON:0001637"},{"id":"T90547","span":{"begin":71,"end":81},"obj":"GO:0007596"},{"id":"T65032","span":{"begin":246,"end":256},"obj":"GO:0042571"}],"text":"Vascular manifestations of COVID-19 comprise either venous or arterial thrombosis or stroke in subjects under the age of 50, sometimes with a severe phenotype that can resemble the “catastrophic” clinical picture associated with antiphospholipid antibodies (aPL)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"444","span":{"begin":27,"end":35},"obj":"Disease"},{"id":"445","span":{"begin":52,"end":81},"obj":"Disease"},{"id":"446","span":{"begin":85,"end":91},"obj":"Disease"},{"id":"447","span":{"begin":258,"end":261},"obj":"Disease"}],"attributes":[{"id":"A444","pred":"tao:has_database_id","subj":"444","obj":"MESH:C000657245"},{"id":"A445","pred":"tao:has_database_id","subj":"445","obj":"MESH:D020246"},{"id":"A446","pred":"tao:has_database_id","subj":"446","obj":"MESH:D020521"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Vascular manifestations of COVID-19 comprise either venous or arterial thrombosis or stroke in subjects under the age of 50, sometimes with a severe phenotype that can resemble the “catastrophic” clinical picture associated with antiphospholipid antibodies (aPL)."}